Piper Sandler Reiterates Overweight on Stereotaxis, Lowers Price Target to $3.5

Benzinga Newsdesk www.benzinga.com Negative 90.5%

Neg 90.5% Neu 0% Pos 0%

Piper Sandler analyst Adam Maeder reiterates Stereotaxis (AMEX:STXS) with a Overweight and lowers the price target from $4 to $3.5.